This monopoly power is commonly seen as a well-deserved reward to the manufacturer for its investment in research and development and discovery of new drugs to benefit the public health
Their ability to lower HbA1c levels in Type 2 Diabetes (T2D), combined with impressive weightloss benefits, has made them a favorite among both doctors and patients, fueling brand and indication conflation while driving rapid growth and popularity
These are all talking about a similar concept: using lower-than-usual amounts of GLP-1based drugs and increasing more slowly than standard protocols, under medical supervision
The past this kind of thing was a pretty good indicator of an economic downturn
Moreover, dulaglutide produces greater weight loss in CNS GIPR knockout (KO) mice, and the weight loss achieved with dulaglutide + GIPR-Ab is attenuated in CNS GIPR KO mice
Patients with PCOS experience excess production of androgens, which disrupts ovulation and leads to irregular menstrual cycles, infertility, acne, excess hair growth, and weight gain ( 1 , 2 )
